[CLSTR]
< Back to situation

[REVISION HISTORY]

Pfizer Catania labor dispute and reindustrialization efforts

Updated 2 times since CLSTR started tracking revisions of this situation.

What changed

2026-10-20 17:10 UTC → 2026-10-25 18:05 UTC · added removed

A labor dispute has emerged at the Pfizer-owned Wyeth Lederle plant in Catania, Italy, following a collective redundancy procedure initiated on July 2, 2026. The procedure involves 330 redundancies out of a 540-person workforce and includes a proposal to close two departments. Negotiations regarding mitigation measures have reached a stalemate among labor organizations. While unions including Filctem-Cgil, Femca-Cisl, Uiltec-Uil, and Ugl Chimici signed a proposal featuring early retirement, relocation, and exit incentives, the FIALC CISAL union refused to sign. Secretary Giuseppe La Mendola argued that the current procedure serves the company’s interests rather than the workers and that signing would imply endorsing an incorrect process. Recent developments indicate a potential shift workers. Efforts toward reindustrialization. Following discussions at the Ministry of Enterprises and Made in Italy, reindustrialization have gained momentum as three international pharmaceutical companies have expressed interest in acquiring the plant. The Ministry Following a postponement of Enterprises and Made key meetings in Italy and late September, where unions requested a suspension of redundancy terms to evaluate alternatives, the Italian Ministry of Labour intend to verify has extended the reliability of these potential buyers, aiming deadline for the industrial procedure to define a reindustrialization plan December 9. This extension, requested by December. While Pfizer has previously contacted 70 potential buyers without success, labor unions—including CGIL, CISL, UIL, and UGL—are now calling for a structured process major trade unions, aims to protect provide sufficient time to assess the 540 workers industrial plans presented by the interested companies. Minister of Enterprises and preserve technical expertise. Pfizer has clarified Made in Italy, Adolfo Urso, stated the government aims to identify a path that its current collective redundancy procedures do not involve revalues the Catania site, treating it as facility and its workforce while ensuring uninterrupted production. The Ministry will oversee discussions with potential investors to determine if their proposals can lead to a separate matter. concrete relaunch of the plant. Authorities are evaluating continue to evaluate voluntary exit schemes and early retirement options as part of the transition, with follow-up meetings scheduled to discuss timelines and the feasibility of the new offers. transition.

Versions

  1. 2026-10-25 18:05 UTC Pfizer Catania labor dispute and reindustrialization efforts
  2. 2026-10-20 17:10 UTC Pfizer Catania labor dispute and reindustrialization efforts
  3. 2026-10-16 07:43 UTC Pfizer Catania labor dispute

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.